Rectal cancer chemoradiotherapy was tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

The Phase I/II trial will evaluate the safety and early efficacy of ABT-301 in combination with tislelizumab and bevacizumab ...

Colorectal cancer cases are increasing among adults under 50, with screening guidelines now recommending starting at age 45.

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

An expert discusses how clinics can successfully implement gene therapy workflows by establishing strong institutional protocols, assigning dedicated clinic coordinators, and using strategies like ...

Pathologic complete response does not predict overall or disease-free survival in patients with rectal cancer, according to a ...

Revenue (GAAP) missed expectations, falling to $156.8 million in Q2 2025—down approximately 14% from the prior year quarter and 5.4% below analyst estimates. GAAP net loss deepened to $0.19 per share, ...

A stunning clinical trial has delivered results that doctors rarely see. Every single patient in the study saw their rectal ...

Coffee enema's have become the latest alarming health trend being popularised on social media - but experts issue warnings ...

A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, ...

Hard bowel movements, pushing too hard, sitting too long, skipping lube or using the wrong kind, toys that are too big — or ...

The tissue damage, anatomical distortion, and lack of surgical landmarks caused by the primary treatment present major challenges to surgeons performing salvage RARP.